Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ)
CNY 10.24
(0.29%)
CNY 10.24
(0.29%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.91 Billion CNY | 3.69% |
| 2022 | 1.84 Billion CNY | 20.95% |
| 2021 | 1.52 Billion CNY | -0.75% |
| 2020 | 1.53 Billion CNY | 41.74% |
| 2019 | 1.08 Billion CNY | 10.09% |
| 2018 | 984.31 Million CNY | 14.94% |
| 2017 | 856.4 Million CNY | 55.84% |
| 2016 | 549.53 Million CNY | 10.05% |
| 2015 | 499.36 Million CNY | 6.76% |
| 2014 | 467.75 Million CNY | 23.18% |
| 2013 | 379.74 Million CNY | 12.74% |
| 2012 | 336.84 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 1.96 Billion CNY | 4.39% |
| 2024 Q2 | 1.88 Billion CNY | -1.15% |
| 2024 Q1 | 1.9 Billion CNY | -0.48% |
| 2023 Q3 | 2.07 Billion CNY | 4.33% |
| 2023 Q4 | 1.91 Billion CNY | -7.74% |
| 2023 FY | 1.91 Billion CNY | 3.69% |
| 2023 Q1 | 1.9 Billion CNY | 3.18% |
| 2023 Q2 | 1.98 Billion CNY | 4.39% |
| 2022 Q3 | 1.64 Billion CNY | 1.45% |
| 2022 Q2 | 1.62 Billion CNY | 2.06% |
| 2022 Q1 | 1.58 Billion CNY | 4.2% |
| 2022 FY | 1.84 Billion CNY | 20.95% |
| 2022 Q4 | 1.84 Billion CNY | 12.11% |
| 2021 FY | 1.52 Billion CNY | -0.75% |
| 2021 Q4 | 1.52 Billion CNY | -1.85% |
| 2021 Q2 | 1.53 Billion CNY | 0.55% |
| 2021 Q1 | 1.52 Billion CNY | -0.66% |
| 2021 Q3 | 1.55 Billion CNY | 1.25% |
| 2020 Q4 | 1.53 Billion CNY | 9.66% |
| 2020 FY | 1.53 Billion CNY | 41.74% |
| 2020 Q1 | 1.23 Billion CNY | 14.43% |
| 2020 Q2 | 1.35 Billion CNY | 9.15% |
| 2020 Q3 | 1.4 Billion CNY | 3.49% |
| 2019 Q2 | 1.01 Billion CNY | 3.49% |
| 2019 FY | 1.08 Billion CNY | 10.09% |
| 2019 Q4 | 1.08 Billion CNY | -3.8% |
| 2019 Q3 | 1.12 Billion CNY | 11.4% |
| 2019 Q1 | 977.05 Million CNY | -0.74% |
| 2018 Q1 | 914.71 Million CNY | 6.81% |
| 2018 Q2 | 942.7 Million CNY | 3.06% |
| 2018 FY | 984.31 Million CNY | 14.94% |
| 2018 Q3 | 994.23 Million CNY | 5.47% |
| 2018 Q4 | 984.31 Million CNY | -1.0% |
| 2017 Q4 | 856.4 Million CNY | -6.84% |
| 2017 FY | 856.4 Million CNY | 55.84% |
| 2017 Q1 | 545.84 Million CNY | -0.67% |
| 2017 Q2 | 862.48 Million CNY | 58.01% |
| 2017 Q3 | 919.25 Million CNY | 6.58% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 Q4 | 549.53 Million CNY | 0.0% |
| 2016 FY | 549.53 Million CNY | 10.05% |
| 2016 Q2 | 509.85 Million CNY | 0.0% |
| 2015 Q3 | 499.36 Million CNY | 6.11% |
| 2015 Q4 | 499.36 Million CNY | 0.0% |
| 2015 Q2 | 470.6 Million CNY | 0.0% |
| 2015 Q1 | 470.6 Million CNY | 0.61% |
| 2015 FY | 499.36 Million CNY | 6.76% |
| 2014 FY | 467.75 Million CNY | 23.18% |
| 2014 Q4 | 467.75 Million CNY | 0.0% |
| 2014 Q3 | 467.75 Million CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2013 FY | 379.74 Million CNY | 12.74% |
| 2012 FY | 336.84 Million CNY | 0.0% |